Dragonfly Biosciences, manufacturers of DragonflyCBD oil has acquired full ownership of Premium Extraction Services Limited – a large-scale state-of-the-art ethanol extraction facility.
This acquisition adds to Dragonfly Bioscience’s expanding portfolio and position in the CBD market.
The expansion will enable Dragonfly Biosciences to deliver bespoke CBD Distillate and CBD isolate in significant quantities.
The extraction facility allows large-scale delivery of over 1000kg of CBD per month, in comparison to other extraction facilities which can deliver on average around 50kg per month.
Regan Saveall, Chief Executive at Dragonfly Biosciences said: “The acquisition of the Premium Extraction Services Company is a significant step forward for Dragonfly Biosciences and importantly our range of CBD products. We are committed to innovation and investment, and already have our own vertical integrated supply chain, which allows us to provide high-quality CBD products, all of which are compliant with all regulatory status.
“By investing as a company, we can ensure our CBD brand is as always safe, legal and best in class when it comes to quality and consumer transparency.
“The extraction facility will enable us to control and produce even more first-class CBD on a much larger scale. This will support the demand for our current products and allow us to explore different types of CBD offerings. There are only a handful of large-scale fully permitted facilities in the EU, so this is really exciting for us.”